Ranga R Krishnan
Overview
Explore the profile of Ranga R Krishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milaneschi Y, Arnold M, Kastenmuller G, Mahmoudian Dehkordi S, Krishnan R, Dunlop B, et al.
J Affect Disord
. 2022 Apr;
307:254-263.
PMID: 35381295
Background: Altered metabolism of acylcarnitines - transporting fatty acids to mitochondria - may link cellular energy dysfunction to depression. We examined the potential causal role of acylcarnitine metabolism in depression...
2.
Brydges C, Fiehn O, Mayberg H, Schreiber H, Mahmoudian Dehkordi S, Bhattacharyya S, et al.
Sci Rep
. 2021 Oct;
11(1):21011.
PMID: 34697401
It is unknown whether indoles, metabolites of tryptophan that are derived entirely from bacterial metabolism in the gut, are associated with symptoms of depression and anxiety. Serum samples (baseline, 12 ...
3.
Bhattacharyya S, Dunlop B, Mahmoudiandehkordi S, Ahmed A, Louie G, Frye M, et al.
Front Neurosci
. 2019 Oct;
13:926.
PMID: 31572108
Major depressive disorder (MDD) is a common and disabling syndrome with multiple etiologies that is defined by clinically elicited signs and symptoms. In hopes of developing a list of candidate...
4.
Bhattacharyya S, Ahmed A, Arnold M, Liu D, Luo C, Zhu H, et al.
Transl Psychiatry
. 2019 Jul;
9(1):173.
PMID: 31273200
Metabolomics provides valuable tools for the study of drug effects, unraveling the mechanism of action and variation in response due to treatment. In this study we used electrochemistry-based targeted metabolomics...
5.
Krishnan R
Dialogues Clin Neurosci
. 2015 May;
17(1):79-87.
PMID: 25987866
Current taxonomic approaches in medicine and psychiatry are limited in validity and utility. They do serve simple communication purposes for medical coding, teaching, and reimbursement, but they are not suited...
6.
Dzirasa K, Krishnan R, Williams R
Acad Med
. 2014 Nov;
90(2):176-9.
PMID: 25406610
Problem: Physician-scientists play a critical role in discovering new biological knowledge and translating findings into medical practices that can improve clinical outcomes. Collectively, the National Institutes of Health (NIH) and...
7.
Zhu H, Bogdanov M, Boyle S, Matson W, Sharma S, Matson S, et al.
PLoS One
. 2013 Jul;
8(7):e68283.
PMID: 23874572
Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to...
8.
Sheline Y, Disabato B, Hranilovich J, Morris C, DAngelo G, Pieper C, et al.
Am J Psychiatry
. 2013 Mar;
169(11):1185-93.
PMID: 23534057
Objective: In order to assess the effect of gray matter volumes and cortical thickness on antidepressant treatment response in late-life depression, the authors examined the relationship between brain regions identified...
9.
10.
Kaddurah-Daouk R, Yuan P, Boyle S, Matson W, Wang Z, Zeng Z, et al.
Sci Rep
. 2012 Sep;
2:667.
PMID: 22993692
Targeted metabolomics provides an approach to quantify metabolites involved in specific molecular pathways. We applied an electrochemistry-based, targeted metabolomics platform to define changes in tryptophan, tyrosine, purine and related pathways...